TD Securities Analysts Give Cronos Group (TSE:CRON) a C$4.50 Price Target

TD Securities set a C$4.50 price target on Cronos Group (TSE:CRON) in a research note released on Tuesday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.

Separately, Canaccord Genuity Group set a C$4.25 price objective on Cronos Group and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of C$4.38.

Cronos Group Trading Down 3.4%

TSE:CRON opened at C$3.67 on Tuesday. Cronos Group has a 12-month low of C$2.27 and a 12-month high of C$4.66. The firm has a market capitalization of C$1.41 billion, a P/E ratio of 33.36, a P/E/G ratio of 0.12 and a beta of 1.21. The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01. The business has a 50 day simple moving average of C$3.65 and a 200 day simple moving average of C$3.60.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.